The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 04, 2022
Filed:
Aug. 12, 2019
Applicants:
Csl Behring Gene Therapy, Inc., Pasadena, CA (US);
Csl Gene Therapy Pty Ltd., Parkville, AU;
Inventors:
Christopher Walter Alma, Castle Hill, AU;
Jeffrey Bartlett, Columbus, OH (US);
Louis Randall Breton, Tucson, AZ (US);
Geoffrey Phillip Symonds, Rose Bay, AU;
Ming Yan, Encino, CA (US);
Assignees:
CSL Behring Gene Therapy, Inc., Pasadena, CA (US);
CSL Gene Therapy Pty Ltd., Parkville, AU;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 35/28 (2015.01); A61P 37/06 (2006.01); A61P 35/02 (2006.01); C12N 5/0783 (2010.01); A61K 35/12 (2015.01); A61K 31/52 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 35/28 (2013.01); A61P 35/02 (2018.01); A61P 37/06 (2018.01); C12N 5/0637 (2013.01); A61K 31/52 (2013.01); A61K 2035/124 (2013.01);
Abstract
The disclosed methods are generally directed to preventing, treating, suppressing, controlling or otherwise mitigating side effects of T-cell therapy, the T-cell therapy designed to accelerate immune reconstitution, induce a GVM effect, and/or target tumor cells.